BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7545212)

  • 1. Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: a new marker of HCV infection closely associated with viremia.
    Lesniewski R; Okasinski G; Carrick R; Van Sant C; Desai S; Johnson R; Scheffel J; Moore B; Mushahwar I
    J Med Virol; 1995 Apr; 45(4):415-22. PubMed ID: 7545212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
    León P; López JA; Elola C; Domingo CJ; Echevarria JM
    Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of anti-E2 in the diagnosis of HCV infection in patients on maintenance hemodialysis: anti-E2 is frequently detected among anti-HCV antibody-negative patients.
    Lee DS; Lesniewski RR; Sung YC; Min WK; Park SG; Lee KH; Kim HS
    J Am Soc Nephrol; 1996 Nov; 7(11):2409-13. PubMed ID: 8959633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic events during the incubation period of hepatitis C virus infection: the role of antibodies to E2 glycoprotein. Multicentre Hemodialysis Cohort Study on Viral Hepatitis.
    Psichogiou M; Katsoulidou A; Vaindirli E; Francis B; Lee SR; Hatzakis A
    Transfusion; 1997 Aug; 37(8):858-62. PubMed ID: 9280333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody to GBV-C second envelope glycoprotein (anti-GBV-C E2): is it a marker for immunity?
    Hassoba HM; Terrault NA; el-Gohary AM; Scheffel C; Jou C; Brackett J; Hunt J; Lou SC; Wright TL
    J Med Virol; 1997 Dec; 53(4):354-60. PubMed ID: 9407383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2 and NS5: new antigens for detection of hepatitis C virus antibodies.
    Zaaijer HL; Vallari DS; Cunningham M; Lesniewski R; Reesink HW; van der Poel CL; Lelie PN
    J Med Virol; 1994 Dec; 44(4):395-7. PubMed ID: 7534821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confirmation of hepatitis C infection: a comparison of five immunoblot assays.
    Zaaijer HL; Vrielink H; van Exel-Oehlers PJ; Cuypers HT; Lelie PN
    Transfusion; 1994 Jul; 34(7):603-7. PubMed ID: 7519796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of hepatitis C virus envelope proteins expressed in E. coli and insect cells for use as tools for antibody screening.
    Hüssy P; Faust H; Wagner JC; Schmid G; Mous J; Jacobsen H
    J Hepatol; 1997 Jun; 26(6):1179-86. PubMed ID: 9210602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
    Sheng L; Soumillion A; Peerlinck K; Verslype C; Schelstraete R; Gyselinck F; Emonds MP; Hess G; Vermylen J; Desmyter J; Yap SH
    Thromb Haemost; 1998 Apr; 79(4):752-5. PubMed ID: 9569187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.
    Hanuka N; Sikuler E; Tovbin D; Neville L; Nussbaum O; Mostoslavsky M; Orgel M; Yaari A; Manor S; Dagan S; Hilzenrat N; Shemer-Avni Y
    J Med Virol; 2004 Aug; 73(4):529-35. PubMed ID: 15221896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen.
    León P; López JA; Elola C; Lee SR; Calmann M; Echevarría JM
    Vox Sang; 1998; 75(1):32-6. PubMed ID: 9745151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay.
    Gonçales NS; Costa FF; Vassallo J; Gonçales FL
    Rev Inst Med Trop Sao Paulo; 2000; 42(5):263-7. PubMed ID: 11058936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.
    Galel SA; Strong DM; Tegtmeier GE; Holland PV; Kuramoto IK; Kemper M; Pietrelli L; Gallarda J
    Transfusion; 2002 Nov; 42(11):1507-13. PubMed ID: 12421226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of hepatitis G virus infection compared with hepatitis C virus infection in patients undergoing chronic hemodialysis.
    Sheng L; Widyastuti A; Kosala H; Donck J; Vanrenterghem Y; Setijoso E; Soumillion A; Verslype C; Schelstraete R; Emonds MP; Hess G; Yap SH
    Am J Kidney Dis; 1998 Feb; 31(2):218-23. PubMed ID: 9469490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative signal of anti-HCV by an automated assay predicts viremia in a population at high prevalence of hepatitis C virus infection.
    Bossi V; Galli C
    J Clin Virol; 2004 May; 30(1):45-9. PubMed ID: 15072753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
    Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
    Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of glycoprotein hepatitis C virus in mammalian cell and application of purified protein for detection of antibody against E2 in hepatitis C patients].
    Zhu C; Wu C; Tao Q
    Zhonghua Gan Zang Bing Za Zhi; 1999 Dec; 7(4):214-6. PubMed ID: 10715790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.
    Cerino A; Bissolati M; Cividini A; Nicosia A; Esumi M; Hayashi N; Mizuno K; Slobbe R; Oudshoorn P; Silini E; Asti M; Mondelli MU
    J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors.
    Tacke M; Schmolke S; Schlueter V; Sauleda S; Esteban JI; Tanaka E; Kiyosawa K; Alter HJ; Schmitt U; Hess G; Ofenloch-Haehnle B; Engel AM
    Hepatology; 1997 Dec; 26(6):1626-33. PubMed ID: 9398008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection.
    Yuki N; Hayashi N; Kasahara A; Hagiwara H; Mita E; Ohkawa K; Katayama K; Fusamoto H; Kamada T
    Hepatology; 1996 May; 23(5):947-52. PubMed ID: 8621173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.